Are There Any Notable Examples of Compulsory Licensing in Cancer Treatment?
One notable example is India's issuance of a compulsory license for the cancer drug Nexavar (sorafenib tosylate) in 2012. The license allowed a local manufacturer to produce a generic version of the drug at a fraction of the original cost, significantly improving accessibility for patients.
